Bone cell study explores direct effects of burosumab and vitamin d

NCT ID NCT04159675

Recruiting now Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Feb 06, 2026 · Last updated May 15, 2026 · Updated 11 times

Summary

This study looks at bone cells from children having surgery for craniosynostosis (early skull bone fusion). Researchers want to see how burosumab and vitamin D directly affect these cells, especially in children with a rare bone disease called hypophosphatemic rickets. The goal is to learn more about how these treatments work on bone, not to test a new therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRANIOSYNOSTOSES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Centre de référence des craniosténoses et malformations cranio-faciales Service de neurochirurgie Pédiatrique
RECRUITING

Bron, 69500, France

Contact

Contact Email: •••••@•••••

Contact

Contact Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

CRANIOSYNOSTOSES